Fevipiprant,a selective prostaglandin D2 receptor 2 antagonist,inhibits human group 2 innate lymphoid cell aggregation and function期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Fevipiprant,a selective prostaglandin D2 receptor 2 antagonist,inhibits human group 2 innate lymphoid cell aggregation and function

Authors:	Clare Hardman Wentao Chen Jian Luo Paul Batty Yi-Ling Chen Janina Nahler Yanqiu Wu Ian D. Pavord Veit J. Erpenbeck David A. Sandham Luzheng Xue Graham Ogg

Affiliation:	1. MRC Human Immunology Unit and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom;2. Respiratory Medicine Unit and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom;3. Novartis Pharma AG, Basel, Switzerland;4. Novartis Institutes for Biomedical Research, Cambridge, Mass

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！